SULFONATED XANTHENE DERIVATIVES

Abstract: The present invention describes xanthene dyes, including rhodamines, rhodols and fluoresceins that are substituted one or more times by a sulfonic acid or a salt of a sulfonic acid. The dyes of the invention, including chemically reactive dyes and dye-conjugates are useful as fluorescent probes, particularly in biological samples.

Description: SULFONATED XANTHENE DERIVATIVES TECHNICAL FIELD The invention relates to novel sulfonated xanthene dyes (including rhodamines, fluoresceins and rhodol dyes), reactive dye derivatives, and dye-conjugates, and to their use in biological systems. BACKGROUND ART The dyes of this invention are xanthene dyes, including fluorescein, rhodol and rhodamme dyes, that are substituted by at least one sulfonate moiety on the xanthene portion of the dye The sulfonated xanthene dyes of the invention possess considerable advantages over their non- sulfonated analogs "Fluorescein" dyes include derivatives of 3i_-xanthen-6-ol-3-one that are typically substituted at the 9-posιtιon by a 2-carboxyphenyl group "Rhodol" dyes include derivatives of 6- ammo-32J-xanthen-3-one that are typically substituted at the 9-posιtιon by a 2-carboxyphenyl group "Rhodamme" dyes include derivatives of 6-ammo-3i_-xanthen-3-ιmme that are typically substituted at the 9-posιtιon by a 2-carboxyphenyl group Fluorescein Rhodol Rhodamme Rhodols, rhodamines and fluoresceins are typically substituted by a derivative capable of forming a 5- or 6-membered lactone or lactam ring. For example in the case of fluorescein the sprrolactone form of the dye has the structure: DISCLOSURE OF INVENTION Fluorescence yields for the dyes of the invention are typically higher than those of other dyes having comparable spectra (Table 5) The sulfonated dyes of the invention similarly exhibit enhanced resistance to quenching upon protein conjugation (Figure 3), and enhanced photostability (Figure 6). The spectra of the sulfonated rhodamme dyes of the invention are insensitive to pH changes in the range between pH 4 and 10 BRIEF DESCRIPTION OF DRAWINGS Figure 1: The absorption spectra of goat anti-mouse (GAM) IgG conjugates of Compound 5 (Compound 5-GAM) and tetramethylrhodamine (TMR-GAM), as described in Example 38 Figure 2: The fluorescence emission spectra of goat anti-mouse IgG conjugates of Compound 5 (Compound 5 -GAM) and CY-3 dye (CY-3 GAM) at similar degrees of substitution and equal optical densities, when excited at 530 nm, as described in Example 40. Figure 3: Conjugate fluorescence vs. degree of substitution for goat anti-mouse IgG conjugates (Fab2 fragments) of Compound 7 and TEXAS RED-X dye, showing less quenching at high degrees of substitution for the dyes of the invention, as described m Example 40. Figure 4: The fluorescence emission spectra of R-phycoerythrm (R-PE) compared to that of a Compound 24-conjugate of R-phycoerythrm, with excitation at 488 nm, as described m Example 42. Highly efficient energy transfer from the protein to the dye of the invention is demonstrated. Figure 5: Relative photoble aching rates of cells stained with a phalloidm conjugate of the present invention (Compound 35) or fluorescein phalloidm, respectively, as described in Example 45. Relative photobleach g rates demonstrate the superior photostability of the dyes of the present invention. Figure 6: Relative photobleachmg rates of cells stained with goat anti-mouse IgG conjugates of Compound 5 (Compound 5-GAM) and CY-3 dye (CY-3-GAM), as described in Example 45 Relative photobleachmg rates demonstrate the superior photostability of the dyes of the present invention Figure 7. The fluorescence emission spectra of cross-linked allophycocyamn (XL-APC) compared to that of a Compound 19-conjugate of cross-hnked allophycocyamn (Compound 19-XL-APC) (Example 59) The addition of the sulfonated rhodamme dye greatly enhances the fluorescence emission at 650 nm via energy transfer from the dye of the invention to the fluorescent protein SUMMARY OF THE INVENTION AND DESCRIPTION OF PREFERRED EMBODIMENTS The present invention describes xanthene dyes that are substituted one or more times by a sulfonic acid or a salt of a sulfonic acid that are useful as fluorescent probes The dyes of the invention optionally possess a reactive group useful for preparing fluorescent conjugates. The compounds of the invention are xanthenes, including fluoresceins, rhodamines and rhodols, that are substituted one or more times by -SO3X or -CH2SO3X, where X is H (sulfonic acid), or a counterion (salt of a sulfonic acid). As used herein, where X is a counterion, it is typically a cation that is not toxic as used, and does not have a substantially deleterious effect on biomolecules Examples of suitable cations include, among others, K + , Na + , Cs + , Lι + , Ca 2+ , Mg 2+ , ammonium, alkylammonium or alkoxyammonium salts, or pyridmium salts Alternatively, the counterion of the sulfonic acid may form an inner salt with a positively charged atom on the xanthene dye itself, typically the quaternary nitrogen atom of a rhodamme dye. In one embodiment, the dyes have formula I or formula II, as shown below Formula I Formula II Substituents R 2 , R 3 , R 4 and R 5 are independently H, F, Cl, Br, I, CN; or Ci-Cis alkyl, or Ci- Ci8 alkoxy, where each alkyl or alkoxy is optionally further substituted by F, Cl, Br, I, a carboxyhc acid, a salt of carboxyhc acid, or a carboxyhc acid ester of a Ci-Cβ alcohol Alternatively one or more of R 2 , R 3 , R 4 and R 5 are -SO3X, or -L-R x , or -L-S c , where L is a covalent linkage, R x is a reactive group, and Sc is a conjugated substance. In a preferred embodiment, R 3 and R 4 are each -SO3X Substituents R 1 and R 6 are H, or R 1 taken in combination with R 2 , or R 5 taken m combination with R 6 , or both, form a fused aromatic six membered ring, that is optionally substituted by one or more -SO3X moieties. In one embodiment of the invention, R 2 , R 3 , R 4 and R 5 are independently H, F, Cl, Br, I or Ci- C18 alkyl In another embodiment of the invention, R 1 , R 2 , R 5 and R 6 are H In yet another embodiment of the invention, R 2 and R 5 are each F or Cl The A moiety is OR 7 , where R 7 is H, Ci-Ciβ alkyl, or -L-R x , or -L-S c Alternatively, A is NR 8 R 9 where R 8 and R 9 are independently H, Ci-Cβ alkyl, CI-CG carboxyalkyl, Ci-Cβ sulfoalkyl, a salt of Ci- Cβ carboxyalkyl, or a salt of Ci-Cβ sulfoalkyl, where the alkyl portions of each are independently and optionally substituted by ammo, hydroxy, carboxyhc acid, a salt of carboxyhc acid, or a carboxvlic acid ester of a Ci-Cβ alkyl Alternatively, R 8 in combination with R 9 forms a saturated 5- or 6- membered heterocycle that is a piperidme, a morpholme, a pyrrohdme or a piperazme, each of which is optionally substituted by methyl, carboxyhc acid, a salt of carboxyhc acid, or a carboxyhc acid ester of a Ci-Cβ alkyl. In another alternative, one or both of R 8 and R 9 are -L-R x or -L-Sc. In another aspect of the invention, R 8 m combination with R 2 , or R 9 m combination with R 3 , or both, form a 5- or 6-membered ring that is saturated or unsaturated, and is optionally substituted by one or more Ci-Cβ alkyls or -CH2SO3X moieties. The B moiety, when present, is 0 or N + R 18 R 19 , where R 18 and R 19 are independently H, Ci-Cβ alkyl, Ci-Cβ carboxyalkyl, Ci-Cc sulfoalkyl, a salt of Ci-Cβ carboxyalkyl, or a salt of Ci-Ce sulfoalkyl, wherein the alkyl portions of each are optionally substituted by ammo, hydroxy, carboxyhc acid, a salt of carboxyhc acid, or a carboxyhc acid ester of a CI-CG alkyl Alternatively, R 18 in combination with R 19 forms a saturated 5- or 6-membered heterocycle that is a piperidme, a morpholme, a pyrrohdme or a piperazme, each of which is optionally substituted by methyl, carboxyhc acid, a salt of carboxyhc acid, or a carboxyhc acid ester of a Ci-Cβ alkyl In another alternative, one or both of R 18 and R 19 are -L-R x , or -L-S c In another aspect of the invention, R 18 in combination with R 4 , or R 19 in combination with R s , or both, form a 5- or 6-membered ring that is saturated or unsaturated, and is optionally substituted by one or more Ci-Cβ alkyls or -CH2SO3X moieties The C moiety, when present, is OR 17 , where R 17 is H, Ci-Ciβ alkyl, or -L-R x , or -L-S c . Alternatively, C is NR 18 R 19 where R 18 and R 19 are as defined previously. In one embodiment of the invention, R 9 and R 18 are independently H, or carboxyalkyl, salt of carboxyalkyl, sulfoalkyl or a salt of sulfoalkyl, each having 1-6 carbons Typically R 9 and R 18 are H, methyl or ethyl. In another embodiment of the invention, R 8 in combination with R 2 and R 19 in combination with R 5 independently form 5- or 6-membered rings that are saturated or unsaturated, and are optionally substituted by one or more alkyl groups having 1-6 carbons, or by one or more -CH2SO3X moieties. In yet another embodiment of the invention, R 8 m combination with R 2 and R 19 in combination with R 5 independently form 5- or 6-membered rings that are saturated, and are substituted by one or more -CH2SO3X moieties. Some (but not all) examples of fused 5- or 6- membered rings as described herein are provided below (additional substituents, such as sulfonic acid or sulfomethyl moieties not shown). The substituent R 10 is H, F, CN, a carboxyhc acid, a salt of carboxyhc acid, or a carboxyhc acid ester of a C1-C6 alcohol. Alternatively R 10 is a saturated or unsaturated Ci-Cis alkyl that is optionally substituted one or more times by F, Cl, Br, carboxyhc acid, a salt of carboxyhc acid, a carboxyhc acid ester of a CI-CG alcohol, -SO3X, ammo, alkylammo, or dialkylammo, the alkyl groups of each substituent having 1-6 carbons. R 10 is optionally -L-R x or -L-Sc. In another embodiment of the invention, R 10 is an aryl substituent having the formula where the R 12 , R 13 , R 14 , R 15 and R 16 substituents are independently H, F, Cl, Br, I, -S03X, a carboxyhc acid, a salt of carboxyhc acid, CN, nitro, hydroxy, azido, ammo, hydrazino, or R 12 , R 13 , R 14 , R 15 and R 16 are independently Ci-Ciβ alkyl, Ci-Cis alkoxy, Ci-Ciβ alkylthio, Ci-Cis alkanoylamino, Ci- C18 alkylammocarbonyl, C2-C36 dialkylaminocarbonyl, Ci-Ciβ alkyloxycarbonyl, or Cβ-Ciβ arylcarboxamido, the alkyl or aryl portions of which are optionally substituted one or more times by F, Cl, Br, I, hydroxy, carboxyhc acid, a salt of carboxyhc acid, a carboxyhc acid ester of a Ci-Cβ alcohol, -SO3X, ammo, alkylammo, dialkylammo or alkoxy, the alkyl portions of these substituents in turn having 1-6 carbons Alternatively, one pair of adjacent substituents R 13 and R 14 , R 14 and R 15 or R 15 and R 16 , when taken in combination, form a fused 6-membered aromatic ring that is optionally further substituted by carboxyhc acid, or a salt of carboxyhc acid. Alternatively, one of R 12 , R 13 , R 14 , R 15 and R 16 is -L-R x or -L-Sc. In one embodiment of the invention, R 12 , R 13 , R 14 , R 15 , and R 16 are independently H, Cl, F, ammo, nitro, -SO3X, a carboxyhc acid, a salt of carboxyhc acid, or a carboxy-substituted alkylthio having the formula -S-(CH2)nCOOH, where n is 1-15. In another embodiment of the invention, at least three of R 13 , R 14 , R 15 , and R 16 are F or Cl In another embodiment of the invention, one of R 14 and R 15 is a carboxyhc acid, a salt of a carboxyhc acid, or -S-(CH2)nCOOH, where n is 1-15, and the other of R 14 and R 15 is H, F or Cl The R 11 substituent is H, hydroxy, CN or a CI-CG alkoxy In another embodiment of the invention, R 10 in combination with R n forms a 5-membered spirolactone ring or a 5-membered spirosultone ring. Alternatively, R 11 m combination with R 12 forms a 5- or 6-membered spirolactone ring or a 5- or 6-membered spirosultone ring, for example (additional substituents are not shown) The methylene carbons of the spirolactone ring or spirosultone ring are optionally and independently substituted by H, F or CH3. Alternatively, R 10 together with R π is a carbonyl oxygen, according to the simplified formula below (additional substituents are not shown). Dye embodiments that incorporate a spirolactone ring are representative of a structural isomer that may exist equilibrium with the isomer wherein R 12 is a carboxyhc acid, or R 10 is a propionic or butyric acid. Dyes that incorporate a spirosultone ring may exist m equilibrium with the isomer wherein R 12 is a sulfonic acid, or R 10 is a sulfonic acid-substituted ethyl or propyl Isomers that incorporate a spirolactone or spirosultone ring are non-fluorescent until the ring is opened. Where A is OR 7 , B is 0, R 10 is aryl and R 12 is carboxy or -SO3X, the described dye is a fluorescein (Formula I) Where A is OR 7 and C is OR 17 , R 10 is aryl, R u is H, and R 12 is carboxy or -SO3X, the described dye is a dihydrofluorescem (Formula II) Where A is NR 8 R 9 B is 0, R 10 is aryl and R 12 is carboxy, the described dye is a rhodol (Formula I) Where A is NR 8 R 9 , C is OR 17 , R 10 is aryl, R 11 is H, and R 12 is carboxy, the dye is a dihydrorhodol (Formula II) Where A is NR 8 R 9 , B is N + R 18 R 19 , R 10 is aryl, and R 12 is carboxy, the described dye is a rhodamme Where A is NR 8 R 9 , C is NR 18 R 19 , R 10 is aryl, R 11 is H, and R 12 is carboxy, the described dye is a dihydrorhodamme Where the dyes of the invention are fluoresceins, they are preferably sulfonefluorescems (wherein R 12 is - SO3X) Preferably, the dyes of the invention are rhodamines or rhodols, more preferably rhodamines In one embodiment of the invention, at least one of R 2 , R 3 , R 4 , and R 5 is -SO3X, preferably R 3 and R 4 are -SO3X In another embodiment of the invention, R 1 taken m combination with R 2 , or R 5 taken m combination with R 6 or both, form a fused aromatic six-membered ring that is substituted by at least one -SO3X moietv In another embodiment of the invention R 8 in combination with R 2 , or R 9 in combination with R 3 , or R 18 m combination with R 4 , or R 19 in combination with R 5 , form a 5- or 6-membered ring that is saturated or unsaturated, and is substituted by at least one -CH2SO3X moiety Preferably R 8 in combination with R 2 and R 19 in combination with R 5 , form a 5- or 6- membered ring that is saturated or unsaturated, and is substituted by at least one -CH2SO3X moiety Spectral properties of selected dyes are given m Table 1 Table 1: Spectral properties of selected fluorophores of the invention Comugates of Reactive Dyes In one embodiment of the invention, the sulfonated xanthene contains at least one group -L-Rx, where R x is the reactive group that is attached to the fluorophore by a covalent linkage L In certain embodiments, the covalent linkage attaching the sulfonated xanthene to Rx contains multiple intervening atoms that serve as a spacer The dyes with a reactive group (R x ) fluorescently label a wide variety of organic or inorganic substances that contain or are modified to contain functional groups with suitable reactivity, resulting m chemical attachment of the conjugated substance (S c ), represented by -L-S c The reactive group and functional group are typically an electrophile and a nucleophile that can generate a covalent linkage Alternatively, the reactive group is a photoactivatable group Typically, the conjugation reaction between the reactive dye and the substance to be conjugated results in one or more atoms of the reactive group R x to be incorporated into a new linkage L attaching the sulfonated xanthene to the conjugated substance S c Selected examples of functional groups and linkages are shown m Table 2, where the reaction of an electrophihc group and a nucleophihc group yields a covalent linkage Table 2. Examples of some routes to useful covalent linkages * Activated esters, as understood in the art, generally have the formula -COΩ, where Ω is a good leaving group (e.g. succmimidyloxy (-OC4H4O2) sulfosuccimmidyloxy (-OC4H3O2-SO3H), -1-oxybenzotrιazolyl (-OC6H4N3); or an aryloxy group or aryloxy substituted one or more times by electron withdrawing substituents such as mtro, sulfo, fluoro, chloro, cyano, or trifluoromethyl, or combinations thereof, used to form activated aryl esters; or a carboxyhc acid activated by a carbodumide to form an anhydride or mixed anhydride -OCOR a or -OCNR a NHR b , where R a and R b , which may be the same or different, are Ci-Cβ alkyl, Ci-Cβ perfluoroalkyl, or Ci-Cβ alkoxy, or cyclohexyl, 3-dιmethylammopropyl, or N-morphohnoethyl) ** Acyl azides can also rearrange to isocyanates The covalent hnkage L binds the reactive group R x or conjugated substance Sc to the fluorophore, either directly (L is a single bond) or with a combination of stable chemical bonds, optionally including single, double, triple or aromatic carbon-carbon bonds, as well as carbon-nitrogen bonds, nitrogen-nitrogen bonds, carbon-oxygen bonds, carbon-sulfur bonds, phosphorus-oxygen bonds, and phosphorus-mtrogen bonds L typically includes ether, thioether, carboxamide, sulfonamide, urea, urethane or hydrazme moieties. Preferred L moieties have 1-20 nonhydrogen atoms selected from the group consisting of C, N, 0, P, and S; and are composed of any combination of ether, thioether, amme, ester, carboxamide, sulfonamide, hydrazide bonds and aromatic or heteroaromatic bonds Preferably L is a combination of single carbon-carbon bonds and carboxamide or thioether bonds. The longest linear segment of the hnkage L preferably contains 4- 10 nonhydrogen atoms, including one or two heteroatoms Examples of L include substituted or unsubstituted polymethylene, arylene, alkylarylene, arylenealkyl, or arylthio In one embodiment L contains 1-6 carbon atoms, in another, L is a thioether hnkage. In yet another embodiment, L is or incorporates the formula -(CH2)a(CONH(CH2)b) z -, where a has any value from 0-5, b has any value from 1-5 and z is 0 or 1 In yet another embodiment, L is or incorporates a substituted platinum atom as described in U.S Patent No. 5,714,327 to Houthoff et al. (1998) The -L-R x and -L-S c moieties are bound directly to the fluorophore at any of R 2 -R 5 or R 7 -R 16 , preferably at one of R 13 -R 16 , more preferably at R 14 or R 13 , or is present as a substituent on an alkyl, alkoxy, alkylthio or alkylammo substituent. In one embodiment, exactly one of R 2 , R 3 , R 4 , R 5 , R 7 , R 9 , R 10 , R 11 , R 12 , R 13 , R 14 , R 15 or R 16 is an -L-R x or -L-S c moiety In another embodiment, exactly one of R 13 , R 14 , R 15 , or R 16 is an -L-R x or -L-S c moiety. In yet another embodiment, exactly one of R 2 , R 3 , R 4 , R 5 , R 7 , R 8 , R 9 or R 10 is an -L-Rx or -L-S c moiety Choice of the reactive group used to attach the fluorophore to the substance to be conjugated typically depends on the functional group on the substance to be conjugated and the type or length of covalent hnkage desired. The types of functional groups typically present on the organic or inorganic substances include, but are not limited to, amines, thiols, alcohols, phenols, aldehydes, ketones, phosphates, lmidazoles, hydrazmes, hydroxylammes, disubstituted amines, hahdes, epoxides, sulfonate esters, purines, pyrimidmes, carboxyhc acids, or a combination of these groups A single type of reactive site may be available on the substance (typical for polysacchaπdes), or a variety of sites may occur (e.g. amines, thiols, alcohols, phenols), as is typical for proteins. A conjugated substance may be conjugated to more than one fluorophore, which may be the same or different, or to a substance that is additionally modified by a hapten, such as biotin. Although some selectivity can be obtained by careful control of the reaction conditions, selectivity of labehng is best obtained by selection of an appropriate reactive dye. Typically, R x will react with an amine, a thiol, an alcohol, an aldehyde or a ketone In one embodiment, R x is an acrylamide, an activated ester of a carboxyhc acid, an acyl azide, an acyl nitrile, an aldehyde, an alkyl hahde, an amme, an anhydride, an anihne, an aryl hahde, an azide, an aziridme, a boronate, a carboxyhc acid, a diazoalkane, a haloacetamide, a halotriazine, a hydrazme (including hydrazides), an lmido ester, an isocyanate, an isothiocyanate, a maleimide, a phosphoramidite, a sulfonyl hahde, or a thiol group Preferably, R x is a carboxyhc acid, a succimmidyl ester, an amme, a haloacetamide, a hydrazme, an isothiocyanate, a maleimide group or an azidoperfluorobenzamido group Where the reactive group is a photoactivatable group, such as an azide, diazirmyl or azidoaryl derivative, the dye becomes chemically reactive after illumination with light of an appropriate wavelength. Where R x is a succimmidyl ester of a carboxyhc acid, the reactive dye is particularly useful for preparing dye-conjugates of proteins or ohgonucleotides Where R x is a maleimide, the reactive dye is particularly useful for conjugation to thiol-contammg substances Where R x is a hydrazide the reactive dye is particularly useful for conjugation to periodate-oxidized carbohydrates and glycoprotems, and in addition is an aldehyde-fixable polar tracer for cell microinjection The reactive dyes of the invention are useful for the preparation of any conjugated substance that possess a suitable functional group for covalent attachment of the fluorophore Examples of particularly useful dye-conjugates include, among others, conjugates of antigens, steroids, vitamins, drugs, haptens, metabolites, toxms, environmental pollutants, ammo acids, peptides, proteins, nucleic acids, nucleic acid polymers, carbohydrates, hpids, lon-complexmg moieties, and non- biological polymers Alternatively, these are conjugates of cells, cellular systems, cellular fragments, or subcellular particles Examples include, among others, virus particles, bacterial particles, virus components, biological cells (such as ammal cells, plant cells, bacteria, yeast, or protists), or cellular components Sulfonated reactive dyes typically label reactive sites at the cell surface, in cell membranes, organelles, or cytoplasm Preferably the conjugated substance is an ammo acid, peptide, protein, tyramine, polysaccharide, lon-complexmg moiety, nucleotide, nucleic acid polymer, hapten, drug, hormone, hpid, hpid assembly, polymer, polymeric micr op article, biological cell or virus. In one embodiment, conjugates of biological polymers such as peptides, proteins, ohgonucleotides and or nucleic acid polymers are also labeled with a second fluorescent or non- fluorescent dye, including an additional dye of the present invention, to form an energy-transfer pair. In one embodiment, the conjugated substance (Sc) is an ammo acid (including those that are protected or are substituted by phosphates, carbohydrates, or Ci to C22 carboxyhc acids), or is a polymer of ammo acids such as a peptide or protein. Preferred conjugates of peptides contain at least five ammo acids, more preferably 5 to 36 ammo acids Preferred peptides include, but are not limited to, neuropeptides, cytok es, toxms, protease substrates, and protein kmase substrates Preferred protein conjugates include enzymes, antibodies, lectms, glycoprotems, histones, albumins, hpoprotems, avidm, streptavidm, protein A, protein G, phycobihproteins and other fluorescent proteins, hormones, toxms and growth factors. Typically, the conjugated protein is an antibody, an antibody fragment, avidm, streptavidm, a toxm, a lectm, a hormone, or a growth factor Typically where the conjugated substance is a toxin, it is a neuropeptide or a phallotoxm, such as phalloidm. Where the conjugated substance is a phycobihprotein, it is typically a phycoerythrm, a phycocyanm, or an allophycocyamn, preferably B- or R-phycoerythrm, or an allophycocyamn. The phycobihprotein is optionally chemically cross-hnked, particularly a cross-hnked allophycocyamn In this embodiment, the dye of the invention and the phycobihprotein form an energy transfer pair, and exhibit a substantial degree of fluorescence resonance energy transfer (Example 59, Figure 7) Preferably, the dye of the invention acts as a donor dye, and the phycobihprotein acts as the ultimate acceptor, permitting excitation with a 488 nm hght source with very long wavelength fluorescence. Alternatively, the dye is an acceptor dye and the phycobihprotein is the initial donor dye (Examples 41 and 42, Figure 4) Preferably the dye-phycobihprotem conjugate exhibits an effective Stokes shift of > 100 nm, with maximal excitation of the dye at 485-515 nm, and maximal fluorescence emission of the phycobihprotein at 620 nm or greater These energy transfer pairs optionally comprise a chemically reactive group or a conjugated substance, typically attached via the phycobihprotein, to facilitate use as detectable labels or tracers. As with other protein conjugates, the phycobihprotein is optionally labeled with additional fluorophores, which may be the same or different, that function as additional energy transfer dyes, donor dyes, or ultimate emitter dyes. In another embodiment, the conjugated substance (Sc) is a nucleic acid base, nucleoside, nucleotide or a nucleic acid polymer, including those that were modified to possess an additional linker or spacer for attachment of the dyes of the invention, such as an alkynyl hnkage (US Pat 5,047,519), an ammoallyl hnkage (US Pat. 4,711,955) or other hnkage. Preferably, the conjugated nucleotide is a nucleoside tπphosphate or a deoxynucleoside tπphosphate or a dideoxynucleoside triphosphate Preferred nucleic acid polymer conjugates are labeled, single- or multi-stranded, natural or synthetic DNA or RNA, DNA or RNA ohgonucleotides, or DNA RNA hybrids, or incorporate an unusual linker such as morphohne deπvatized phosphates (AntiVirals, Inc., Corvalhs OR), or peptide nucleic acids such as iV-(2-ammoethyl)glycιne umts. When the nucleic acid is a synthetic ohgonucleotide, it typically contains fewer than 50 nucleotides, more typically fewer than 25 nucleotides. Larger fluorescent nucleic acid polymers are typically prepared from labeled nucleotides or ohgonucleotides using ohgonucleotide-pπmed DNA polymerization, such as by using the polymerase chain reaction or through primer extension, or by terminal-transferase catalyzed addition of a labeled nucleotide to a 3 ' -end of a nucleic acid polymer. Typically, the dye is attached via one or more pur e or pyrimidme bases through an amide, ester, ether or thioether bond; or is attached to the phosphate or carbohydrate by a bond that is an ester, thioester, amide, ether or thioether. Alternatively, dye conjugate of the invention is simultaneously labeled with a hapten such as biotm or digoxigemn, or to an enzyme such as alkahne phosphatase, or to a protein such as an antibody Nucleotide conjugates of the invention are readily incorporated by a DNA polymerase and can be used for in situ hybridization (Example 54) and nucleic acid sequencing (e g , US Pats 5,332,666, 5,171,534; and 4,997,928; and WO Appl 94/05688) In another embodiment, the conjugated substance (S c ) is a carbohydrate that is a mono-, di-, or polysacchaπde Typically where S c is a carbohydrate it is a polysacchaπde, such as a dextran, FICOLL, heparm, glycogen, amylopectm, mannan, inuhn, starch, agarose and cellulose. Alternatively, the carbohydrate is a polysacchaπdes that is a hpopolysaccharide. Preferred polysaccharide conjugates are dextran or FICOLL conjugates In another embodiment, the conjugated substance (S c ), is a hpid (typically having 6-60 carbons), including glycohpids, phosphohpids, sphingohpids, and steroids Alternatively, the conjugated substance is a hpid assembly, such as a hposome The hpophihc moiety may be used to retain the conjugated substances m cells, as described m US Pat 5,208, 148 Conjugates having an lon-complexmg moiety serve as indicators for calcium, sodium magnesium, potassium, or other biologically important metal ions Preferred lon-complexmg moieties are crown ethers, including diaryldiaza crown ethers (US Pat 5 405,975), BAPTA chelators (US Pat 5,453,517, US Pat 5,516,911, and US Pat 5,049,673), APTRA chelators (AM J PHYSIOL 256, C540 (1989)); or pyndine- and phenanthrohne-based metal ion chelators (U S Patent No 5,648,270) Preferably the lon-complexing moiety is a diaryldiaza crown ether or BAPTA chelator The ion indicators are optionally conjugated to plastic or biological polymers such as dextrans or microspheres to improve their utility as sensors Alternatively, where the dye is a fluorescein or a rhodol, the dye itself acts as an indicator of H + at pH values withm about 1 5 pH units of the individual dye's pKa. Other conjugates of non-biological materials include dye-conjugates of organic or inorganic polymers polymeric films, polymeric wafers, polymeric membranes, polymeric particles, polymeric microparticles including magnetic and non-magnetic microspheres conducting and non-conductmg metals and non-metals, and glass and plastic surfaces and particles Conjugates are optionally prepared bv copolymerization of a sulfonated dye that contains an appropriate functionality while preparing the polymer, or by chemical modification of a polymer that contains functional groups with suitable chemical reactivity Other types of reactions that are useful for preparing dye- conjugates of polymers include catalyzed polymerizations or copolymerizations of alkenes and reactions of dienes with dienophiles, transesterifications or transaminations In another embodiment, the conjugated substance comprises a glass or silica, which may be formed into an optical fiber or other structure. The preparation of dye conjugates using reactive dyes is well documented, e.g by R. Haugland, MOLECULAR PROBES HANDBOOK OF FLUORESCENT PROBES AND RESEARCH CHEMICALS, Chapters 1-3 (1996), and Brinkley, BIOCONJUGATE CHEM., 3, 2 (1992). Conjugates typically result from mixing appropriate sulfonated reactive dyes and the substance to be conjugated in a suitable solvent in which both are soluble The dyes of the invention are readily soluble m aqueous solutions, facilitating conjugation reactions with most biological materials. For dyes that are photoactivated, conjugation also requires illumination. Labeled members of a specific binding pair are typically used as fluorescent probes for the complementary member of that specific binding pair, each specific binding pair member having an area on the surface or m a cavity that specifically binds to and is complementary with a particular spatial and polar organization of the other. Preferred specific binding pair members are proteins that bind non-covalently to low molecular weight hgands, such as biotm, drug-haptens and fluorescent dyes (such as an anti-fluorescein antibody). Such probes optionally contain a covalently bound moiety that is removed by an enzyme or light, or R u is H and the compound fluoresces following oxidation. Representative specific binding parrs are shown in Table 3. Table 3. Representative Specific Binding Pairs * IgG is an immunoglobulin + aDNA and aRNA are the antisense (complementary) strands used for hybridization In another embodiment of the invention, the sulfonated xanthene dye is substituted by a blocking moiety that substantially alters the fluorescence of the fluorophore, where the subsequent removal of the blocking moiety restores the fluorescence of the parent dye Typically, cleavage of the blocking moiety from the dye is accomplished by enzymatic activity, making the blocked dye an enzyme substrate (for example as described by Mangel et al., U.S Patent No 4,557,862 (1985)) Alternatively, the blocking moiety is a photolabile cagmg group, such as a substituted or unsubstituted derivative of o-mtroarylmethme (including α-carboxy o-mtroarylmethine (U S. Patent No. 5,635,608 to Haugland et al. (1997)) and bιs-(5-t-butoxycarbonylmethoxy)-2-mtrobenzyl), of 2- methoxy-5-mtrophenyl, or of desyl. Enzymes that may be detected or quantitated using appropriately blocked dyes include microsomal dealkylases (for example, cytochrome P450 enzymes), glycosidases (for example β- galactosidase, β-glucosidase, -fucosidase, β-glucosaminidase), phosphatases, sulfatases, esterases, lipases, guamdmobenzoatases and others. Conjugates of rhodol dyes that are ammo acid or peptide amides are typically useful as peptidase substrates. Where the sulfonated xanthene is conjugated to a tyramme molecule, the resulting dye-conjugate is useful as a substrate for peroxidase enzymes (as described in U S Patent No 5,196,306 to Bobrow et al (1993)) The reduced derivatives of xanthyhum dyes (i.e., those of Formula II wherein R 11 is H) serve as substrates for enzymes that take up electrons, or m the detection of chemical oxidizing agents, reactive oxygen species or nitric oxides Sulfonation of the xanthene dyes provides improved water solubility for these substrates Applications and Methods of Use The dye compounds of the invention are generally utihzed by combining a sulfonated xanthene dye compound as described above with the sample of interest under conditions selected to yield a detectable optical response The term "dye compound" is used herein to refer to reactive and non-reactive sulfonated xanthenes and their conjugates. The dye compound typically forms a covalent or non-covalent association or complex with an element of the sample, or is simply present within the bounds of the sample or portion of the sample The sample is then illuminated at a wavelength selected to elicit the optical response Typically, staining the sample is used to determine a specified characteristic of the sample by further comparing the optical response with a standard or expected response. For biological apphcations, the dye compounds of the invention are typically used m an aqueous, mostly aqueous or aqueous-miscible solution prepared according to methods generally known in the art The exact concentration of dye compound is dependent upon the experimental conditions and the desired results, but typically ranges from about one nanomolar to one milhmolar or more. The optimal concentration is determined by systematic variation until satisfactory results with minimal background fluorescence is accomphshed The dye compounds are most advantageously used to stam samples with biological components. The sample may comprise heterogeneous mixtures of components (including mtact cells, cell extracts, bacteria, viruses, organelles, and mixtures thereof) or a single component or homogeneous group of components (e g natural or synthetic ammo acid nucleic acid or carbohydrate polymers, or hpid membrane complexes) These dyes are generally non-toxic to living cells and other biological components, withm the concentrations of use, although those sulfonated dyes that are additionally substituted one or more times by Br or I are efficient photosensitizers The dye compound is combined with the sample in any way that facilitates contact between the dye compound and the sample components of interest Typically, the dye compound or a solution containing the dye compound is simply added to the sample. More so than other xanthene derivatives, sulfonated xanthene derivatives tend to be impermeant to membranes of biological cells, but once inside viable cells are typically well retained Treatments that permeabihze the plasma membrane, such as electroporation, shock treatments or high extracellular ATP can be used to introduce dye compounds into cells Alternatively, the dye compounds are inserted into cells by pressure micro jection, scrape loading, patch clamp methods, phagocytosis, or by osmotic lysis of pmocytic vesicles. Sulfonated xanthene dyes that incorporate an amme or a hydrazme residue can be micromjected into cells, where they can be fixed in place by aldehyde fixatives such as formaldehyde or glutaraldehyde. This fixabihty makes such dyes useful for intracellular apphcations such as neuronal tracing. Solubihzation of the fluorophore m water by the sulfonate moieties and their relative impermeance to membranes gives the dye compounds of the invention particular utihty as polar tracers, according to methods generally known in the art for other dye compounds, see e.g. U.S Patent No. 4,473,693 to Stewart (1984) (using lucifer yellow) and U S. Patent No. 5,514,710 to Haugland et al (1996) (using caged hydroxypyrenesulfonic acids). Where the sulfonated xanthene dyes is photoreactive, the resulting polar tracer is photo-fixable. Dye compounds that possess a hpophihc substituent, such as phosphohpids, will non- covalently incorporate into hpid assemblies, e.g. for use as probes for membrane structure; or for incorporation in hposomes, hpoprotems, films, plastics, hpophihc microspheres or similar materials, or for tracing Lipophihc sulfonated xanthene dyes are useful as fluorescent probes of membrane structure, wherein the sulfonic acid moiety permits trapping of the probe at or near the membrane's surface. Chemically reactive dye compounds will covalently attach to a corresponding functional group on a wide variety of materials Using dye compounds (including photoreactive versions) to label reactive sites on or within cells permits the determination of their presence or quantity, accessibility, or their spatial and temporal distribution m the sample. The relative impermeance of the dyes of the invention to membranes of biological cells, give them utility as fluorescent probes for assessing the topography of protein distribution in living cells, or as an indicator of single cell viability (Example 55) Outside of the cellular milieu, the negative charge of the dye compounds at neutral pH also facihtates the electrophoretic separation of dve-conjugates of carbohydrates, drugs and other low molecular weight compounds for analysis by capillary zone electrophoresis (CZE), HPLC or other separation techniques Precipitation of the conjugate is minimized, even after labehng with multiple fluorophores, since the sulfonated xanthene derivatives are fully ionized at neutral pH. The sample is optionally combined with one or more additional detection reagents. An additional detection reagent typically produces a detectable response due to the presence of a specific cell component, intracellular substance, or cellular condition, according to methods generally known m the art Where the additional detection reagent has, or yields a product with, spectral properties that differ from those of the subject dye compounds, multi-color apphcations are possible This is particularly useful where the additional detection reagent is a dye or dye-conjugate of the present invention having spectral properties that are detectably distinct from those of the other starnmg dye. The compounds of the invention that are dye conjugates are used according to methods extensively known m the art; e.g. use of antibody conjugates in microscopy and immunofluorescent assays; and nucleotide or ohgonucleotide conjugates for nucleic acid hybridization assays and nucleic acid sequencing (e.g., US Patent Nos. 5,332,666 to Prober, et al. (1994), 5,171,534 to Smith, et al. (1992); 4,997,928 to Hobbs (1991), and WO Appl. 94/05688 to Menchen, et al.. Dye-conjugates of multiple independent dyes of the invention possess utihty for multi-color applications Dye-conjugates of antibodies to fluorophores possess utility for amplification of fluorescence. For example, the sulfonated rhodamme dyes of the invention exhibit no crossre activity with anti- fluorescein. The use of anti-fluorescem antibodies conjugated to green fluorescent sulfonated xanthene dyes to amplify fluorescein labels results in both amplification of signal and photostabilization, due to the high photostability of the dyes of the present invention. Labeled antibodies are also useful for multi-color apphcations, as the use of a red fluorescent anti-fluorescem antibody in conjunction with fluorescein labeling results m a bright, photostable red fluorescent signal. At any time after or during staining, the sample is illuminated with a wavelength of hght selected to give a detectable optical response and observed with a means for detecting the optical response Appropriate illuminating equipment includes but is not limited to, hand-held ultraviolet lamps, mercury arc lamps, xenon lamps, lasers and laser diodes These illumination sources are optionally integrated into laser scanners, fluorescence microplate readers, standard or mmifluorometers, or chromatographic detectors A detectable optical response means a change m, or occurrence of, an optical signal that is detectable either by observation or mstrumentally. Typically the detectable response is a change in fluorescence, such as a change in the intensity, excitation or emission wavelength distribution of fluorescence, fluorescence lifetime, fluorescence polarization, or a combination thereof The degree and/or location of staining, compared with a standard or expected response, indicates whether and to what degree the sample possesses a given characteristic The optical response is optionally detected by visual inspection, or by use of any of the following devices CCD cameras, video cameras, photographic film, laser-scanning devices, fluorometers, photodiodes, quantum counters, epifluorescence microscopes, scanning microscopes, flow cytometers, fluorescence microplate readers, or by means for amplifying the signal such as photomultipher tubes Where the sample is examined using a flow cytometer, examination of the sample optionally includes sorting portions of the sample according to their fluorescence response Dve Synthesis Xanthy um dyes are typically prepared by condensation of the appropriate resorcinol or ammophenol with various derivatives of benzoic acid, phthahc acid or phthahc anhydride or sulfobenzoic acid or anhydride This condensation occurs m the presence or absence of various acid catalysts An aqueous workup, typically followed by column chromatography, yields the desired xanthyhum dye. For unsymmetric xanthyhum dyes, such as rhodols, unsymmetrical fluoresceins. or unsymmetrical rhodamines, condensation can be performed using one equivalent each of the appropriate substituted or unsubstituted resorcmol or ammophenol with one equivalent of a different resorcmol, ammophenol and with one equivalent of the appropriate phthahc acid derivative or benzaldehyde (as listed above) using acid catalysis (as in Khanna et al , U.S Patent No 4,439,359 (1984) and Haugland et al., U.S. Patent No. 5,227,487 (1993)). The desired asymmetric xanthyhum dye is separated from any unwanted symmetric dye side-product using crystallization or chromatographic techniques well-known m the art. Unsymmetric xanthyhum dyes can also be constructed in a stepwise fashion A selected resorcmol or ammophenol is condensed with one equivalent of the appropriate phthahc acid derivative or benzaldehyde to yield a benzophenone, which is typically isolated, purified and condensed with one equivalent of a different resorcmol or ammophenol, yielding the asymmetric dye. Sulfonation of xanthyhum dyes is typically carried out by stirring the dye m fuming sulfuric acid (20-30% S0 3 content) or concentrated sulfuric acid at an appropriate temperature Sulfonation occurs either at the 4'- and 5'-posιtιons. if available, or/and at the vmyhc methyl groups of the xanthyhum if the xanthyhum dye is substituted by a vmyhc substituent Sulfonation at the 4'- and 5'-posιtιons of fluorescein derivatives is typically carried out by stirring a solution of the desired fluorescein derivative in fuming sulfuric acid (20-30%) Fluorescein derivatives with electron- donating groups on the xanthyhum ring are typically sulfonated at room temperature, while fluorescein derivatives having electron-withdrawing groups such as fluorine and chlorine on the xanthyhum ring are typically sulfonated at an elevated temperature for example at 100-110 °C Mono-sulfonation of rhodol dyes is carried out by stirring the appropriate rhodol dye m fuming sulfuric acid at 0 °C for several hours Bis-sulfonation of rhodols at both the 4'- and 5 ' -posιtιons, if available, is achieved by stirring the dye m fummg sulfuric acid at room temperature for several hours Sulfonation of most rhodamme or rosamme dyes at the 4'- and 5 ' -posιtιons, if available, is carried out with fuming sulfuric acid at 0 °C, the sulfonation is usually complete as soon as a homogeneous solution is achieved during strrπng. Where the xanthyhum dye possesses a vmyhc methyl group, sulfonation at the vmyhc methyl is accomphshed by treatment with concentrated sulfuric acid at room temperature If the 4'- and 5 '-positions are also available for sulfonation, sulfonation may occur at those positions as well, provided that fummg sulfuric acid is used as the sulfonatmg agent. Post-condensation modifications of xanthyhum dyes are well known. For example, the xanthene portion of the dye can be halogenated by treatment with the appropriate halogenatmg agent, such as liquid bromine. Xanthenes contaimng unsaturated fused rings can be hydrogenated to the saturated derivatives. When tπmelhtic anhydride or its derivatives is used m the dye synthesis, two lsomeric carboxylates are typically formed. These isomers are separated or, m most cases, used as the mixture of isomers. The reduced derivatives of xanthyhum dyes (1 e., those of Formula II wherein R 11 is H) are prepared by chemical reduction of the xanthene portion with zinc dust or borohydride in organic solvents Similarly to nonsulfonated xanthenes, the ammo and hydroxyl groups of sulfonated xanthenes can be acylated or alkylated to yield amides, esters and ethers, some of which are enzyme substrates, caged dyes or fluorescent probes The selection of an appropriate polyhalogenated phthahc acid derivative or benzaldehyde in the condensation of the xanthyhum dye results m a dye having a tetra- or pentachlormated or tetra- or pentafluormated phenyl ring at the 9-posιtιon These polyhaloaryl substituted dyes have been shown to react with thiols via a displacement reaction, and thereby provide a facile method of introducing additional reactive groups (Example 19, and as discussed by Gee, et al TET LETT 37, 7905 (1996)) The dihydro-xanthene and xanthyhum versions of the dyes of the invention are freely interconvertible by well-known oxidation reagents (for example molecular oxygen, nitric oxide, peroxymtrite, dichromate, triphenylcarbemum and chloraml) or reduction reagents (for example borohydrides, aluminum hydrides, hydrogen catalyst and dithiomtes) The xanthenes are also oxidized by enzyme action, including horseradish peroxidase in combination with peroxides or by nitric oxide Examples of synthetic strategies for selected sulfonated fluorophores, as well as their characterization, synthetic precursors, conjugates and method of use are given below The examples below are given so as to illustrate the practice of this invention They are not intended to limit or define the entire scope of this invention EXAMPLES Example 1 Preparation of Compound 2 A mixture of 7-hydroxy-2,2,4-trιmethyl-l,2,3,4-tetrahydroquιnolme (20 g, 74 mmol), trrmelhtic anhydride (10 g, 52 mmol) and ZnC is heated to 220-230 C C with stirring for 3 hrs 150 mL water is added to the hot reaction mixture The resulting precipitate is filtered, washed with water (3 x 50 mL), and dried The crude product is purified on silica gel using MeOH/CHCh Yield 10 g. Example 2. Preparation of Compound 6: Compound 6 is prepared analogously to Compound 2 (Example 1), only using 7-hydroxy- l,2,2,4-tetramethyl-l,2-dιhydroquιnohne (15.2 g, 74.9 mmol). trimellitic anhydride (9.35 g, 48.7 mmol) and p-toluenesulfomc acid (1 g) in propionic acid (50 mL). After heating at reflux for 24 hrs. the mixture is poured into 2% HCl (2 L). The crude product is collected, dried and purified by chromatography using CHCL:MeOH=10:l to 10:3. (8 g, 36%). Example 3. Preparation of Compound 8: Compound 8 is prepared analogously to Compound 6 (Example 2), only using one equivalent each of 8-hydroxyjulolιdme. 7-hydroxy-l,2,3,4-tetrahydroqumolme and trimellitic anhydride. Example 4. Preparation of Compound 15 Compound 15 is prepared analogously to Compound 6 (Example 2), using tetrafluorophthahc anhydride in place of trimellitic anhydride. Example 5. Preparation of Compound 28: A nitro-substituted analog of Compound 6 is prepared from 7-hydroxy-N-methyl-2,2.4- trιmet_yl-l,2-dιhydroquιnolme and 4-nιtrophthahc anhydride using the method described in Example 4. Reduction of the nitro group using the method described by McKmney et al. (McKmney, et al. J. ORG. CHEM. 27, 3986 (1962)) gives Compound 28. Example 6 Preparation of Compound 10: A mixture of 7-hydroxy-l,2.2,4-tetramethyl-l,2,3,4-tetrahydroquιnolme hydrobromide (25.8 g, 94.9 mmol) and 4-carboxybenzaldehyde (7.1 g, 47.3 mmol) is stirred m 120 mL 70% H2SO4 at 130 °C for 4 hrs. The solution is cooled to 0 °C and then neutralized to pH 7 with 70% KOH. The resulting precipitate is filtered, washed with water, and dried. The solid is suspended m 300 mL MeOH and chloraml is added (11.6 g, 47.3 mL). The suspension is heated at reflux for 2 hrs. cooled to room temperature, and rotary evaporated to 100 L. Ether (500 mL) is added and the precipitate is filtered. The crude product is purified by chromatography on silica gel using MeOH/CHClj Yield: 40%. Example 7 Preparation of Compound 13: A mixture of 7-hydroxy-2,2,4-trιmethyl-l,2-dιhydroqumolme (6 g, 22.2 mmol) and 4- carboxybenzaldehyde (2.1 g, 14 mmol) is heated at 150-160 °C with stirring for 6-7 hrs. The mixture is dissolved in MeOH (300 mL), and evaporated to approximately 50 mL, and poured into Et^O (1.2 L). The crude product is collected and purified by chromatography on silica gel using CHCl3.MeOH=7.3. (2.5 g, 21%). Example 8. Preparation of Compound 1: 5-(and-6)-Carboxyrhodamme 110, hydrochloride (8.14 g, 19.8 mmol: Molecular Probes, Inc.. Eugene, OR) is slowly added m portions to 30% fummg H2SO4 (50 mL) m an ice bath. After 12 hrs at 0 °C, the solution is poured into 600 mL cold dioxane, and 1.2 L Et2θ is added. The suspension is filtered through diatomaceous earth. The filter cake is suspended m 1.2 L MeOH and the pH is adjusted to -10 with triethylamme. The mixture is filtered and the filtrate is evaporated. The residue is purified on SEPHADEX LH-20 using water as the eluant to give Compound 1 as an orange solid (9 g). Example 9. Preparation of Compound 3: Compound 3 is prepared from Compound 2 using the method described in Example 8 except that LiOH is used to basify the MeOH suspension. Example 10 Preparation of Compound 9- Compound 9 is prepared from Compound 8 using the procedure described m Example 9 Example 11. Preparation of Compound 11: Compound 11 is prepared from Compound 10 using the procedure described m Example 9 Example 12. Preparation of Compound 17: Compound 17 is prepared from 6-amιno-9-(2',4'-(or-5')-dιcarboxyphenyl)-3i_- anthene-3-one using the procedure described m Example 9 Abs: 493 em (pH 9); Em: 518 nm (pH 9). Example 13 Preparation of Compound 18" 5-Carboxy-2',7'-dιchlorosulfonefluoresceιn (1 g, 2.1 mmol) is added to 15 mL 30% fummg H2SO4. The mixture is heated to 110 °C with stirring for 4 hrs, then cooled to room temperature and poured into ice. The precipitate is filtered then recrystalhzed from 6% NaCl, giving light yellow crystals. Yield: 70% Example 14. Preparation of Compound 7 To concentrated H2SO4 (20 mL) at 0 °C is added Compound 6 (1.7 g, 3.02 mmol). The mixture is stirred at 0 °C for 2 hrs and then at room temperature for 2 days. Dioxane (30 mL) and Et2θ (1 L) are added. The precipitate is filtered through diatomaceous earth The filter cake is suspended in H2O and neutrahzed with sohd NaHC03. After filtration, the filtrate is evaporated and the residue is purified by chromatography on silica gel (eluant: CH3CN:H2θ=8:2) followed by chromatography on SEPHADEX LH-20 (eluant: H2O). The product is converted to a lithium salt by treatment with hthium cation exchange resin. Yield: 0.7 g (31%). Example 15. Preparation of Compound 12: A mixture of Compound 7 (100 mg, 0.14 mmol) and 10% Pd/C (30 mg) m MeOH (10 L) is hydrogenated at 45 psi overnight The crude product is purified by chromatography on silica gel using as eluant (15 mg, 14%) Example 16 Preparation of Compound 16 Compound 16 is prepared from Compound 15 using the method described in Example 14 Example 17 Preparation of Compound 40- H H Compound 40 is prepared from tetrachlorophthahc anhydride and 7-hydroxy-2,2,4- trιmethyl-l,2,3,4-tetrahydroquιnohne using the procedure described m Example 2. Example 18. Preparation of Compound 41: Compound 41 is prepared from Compound 40 and fummg sulfuric acid using the procedure described m Example 8. Abs: 557 (MeOH): Em: 574 nm (MeOH). Example 19 Preparation of Compound 42: To a solution of Compound 42 (425 mg, 0.54 mmol) m 5 mL DMF under nitrogen is added mercaptoacetic acid (99 mg, 1.07 mmol) and sodium acetate (219 mg, 2.67 mmol). The solution is stirred overnight and then evaporated to dryness m vacuo. The crude product is purified by column chromatography on sihca gel elutmg with CH3CNH2O = 85.15. Yield: 79% Example 20. Preparation of Compound 14: Compound 14 is prepared from Compound 13 using the procedure described m Example 14. Example 21. Preparation of Compound 30: Compound 30 is prepared from Compound 28 using the method described in Example 14 Example 22. Preparation of Compound 19: To Compound 1 (200 mg, 0.36 mmol) m 10:4 DMF/H2O (14 mL) at 0 °C is added O- succmιmιdyl-N,N,N',N'-tetramethyluromum tetrafluoroborate (330 mg, 1.10 mmol) m DMF (6 mL). After 30 minutes at 0 °C. the solution is evaporated. The residue is purified by chromatography on sihca gel using CH 3 CN:H 2 0=8:2 as eluant (60 mg, 26%). Example 23. Preparation of Compound 20: Compound 20 is prepared from Compound 11 using the method described in Example 22 Yield: 80%. Example 24. Preparation of Compound 21 • Compound 21 is prepared from Compound 14 using the method described in Example 22 Example 25 Preparation of Compound 22: To a solution of the succimmidyl ester of Compound 7 (prepared using the method of Example 22) (17.3 mg, 21.1 μmol) m H2O (2 mL) is added ammocaproic acid (5 mg, 38 μmol) followed by 8 drops of N,N-dusopropylethylamme. After 15 minutes the solution is evaporated, and the residue is purified on silica gel using CH3CN:H2θ=85:15 as the eluant The product is treated with Lι + cation exchange resin to give Compound 22 (8 mg). Example 26. Preparation of Compound 23: Compound 23 is prepared from Compound 22 using the method described in Example 22. Example 27. Preparation of Compound 26: To Compound 19 (100 mg, 0.16 mmol) m H 2 0 (10 mL) is added N-t-BOC-cadaverme (300 mg, 1.58 mmol) in CH3CN (6 mL). After 45 minutes the mixture is evaporated to dryness. The residue is purified by silica gel chromatography using CHjCN:H2θ = 85:15 The purified compound is dissolved in water and treated with Na + cation exchange resm to give Compound 26 (40 mg, 34%) Example 28. Preparation of Compound 27: To Compound 26 (300 mg, 0.41 mmol) at 0 °C is added cold trifluoroacetic acid (5 mL). After 15 minutes at 0 °C the mixture is evaporated. The residue is dissolved in CH3OH (20 mL) and H 2 O (30 L) with Et3N (2 mL). The solution is evaporated and the residue is purified on SEPHADEX LH-20 to give Compound 27. The Na + salt is prepared using a Na + cation exchange resm. Example 29. Preparation of Compound 43: To a solution of equimolar amounts of Compound 27 and triethylamme in DMF is added one equivalent of 4-azιdo-2,3,5,6-tetrafluorobenzoιc acid, succimmidyl ester. After stirring for 4 hours, the reaction mixture is evaporated and the residue purified by silica gel chromatography to give Compound 43. Example 30 Preparation of Compound 24: To the succimmidyl ester of Compound 7 (10 mg, 12 μmol) m H2O is added N-(5- amιnopentyl)maleιmιde trifluoroacetate (5 mg, 17 μmol) in CH3CN followed by 1 drop of N,N- d sopropylethylamine. After 15 minutes the mixture is evaporated to dryness. The residue is purified by chromatography on silica gel using CH3CN:H2θ=85:15 then converted to the Na + salt using Na + cation exchange resin giving Compound 24 (6 mg). Example 31. Preparation of Compound 25: Compound 25 is prepared from Compound 19 using the method described in Example 30. Example 32. Preparation of Compound 31: Compound 31 is prepared by treating Compound 30 with excess thiophosgene, using the standard method for isothiocyanate preparation. Example 33. Preparation of Compound 33: To Compound 21 (0.28 g, 0.37 mmol) in DMF (10 mL) at 0 °C is added t-butyl carbazate (0 15 g, 1.12 mmol). After 30 minutes the solution is evaporated. The intermediate is purified on silica gel using CH3CN/H2O (9:1). Trifluoroacetic acid (3 mL) is added, the solution is stirred at 0 C C for 15 min and then evaporated. The product is purified on SEPHADEX LH-20 eluting with H2O. The Na + salt is prepared by ion exchange using a Na + cation exchange resm. Example 34 Preparation of a phalloidm comugate of a sulfonated rhodamme (Compound 35) To ammophalloidmp-toluenesulfonate (3.5 mg, 4 μmol) and the succimmidyl ester of Compound 7 (5.0 mg, 5 μmol) in DMF is added N,N-dusopropylethylamme (3 μL, 17 μmol). The mixture is stirred at room temperature for 3 hours. To this is added 7 mL of diethyl ether The solid is collected by centrifugation. The crude product is purified on SEPHADEX LH-20, elutmg with water to give pure Compound 35 (4.0 mg). Example 35. Preparation of a nucleotide dve-comugate: To 2 mg of 5-(3-amιnoallyl)-2'-deoxyurιdme 5'-trιphosphate (Sigma Chemical) in 100 μL water is added 3 mg of Compound 19 in 100 μL DMF and 5 μL triethylamme. After 3 hours, the solution is evaporated and the residue is purified by HPLC. The product fractions are Ivophihzed to give the green fluorescent nucleotide conjugate (Compound 36). Alternatively fluorescent dye-conjugates of deoxyuridme 5'-tπphosphate are prepared from 5-(3-ammo-l-propynyl)-2'-deoxyuπdιne 5'-trιphosphate (as described in Hobbs, Jr. et al, supra) Example 36. Preparation of an ohgonucleotide dve-comugate A 5'-amme modified, 18-base M13 primer sequence (-100 μg) is dissolved in 4 μL 0.1 M Tris- EDTA buffer. To this is added 250 μg of Compound 25 (Example 31) in 100 μL 0.1 M sodium borate, pH 8.5. After 16 hours, 10 uL of 5 M NaCl and 3 volumes of cold ethanol are added The mixture is cooled to -20 °C, centnfuged, the supernatant is decanted, the pellet is rinsed with ethanol and then dissolved in 100 μL H2O. The labeled ohgonucleotide is purified by HPLC on a 300A C8 reverse- phase column using a ramp gradient of 0.1 M triethylammonium acetate (pH -7) and acetonitnle (5→45% over 40 mm). The desired peak is collected and evaporated to give the fluorescent ohgonucleotide. Example 37. Preparation of a drug dve-comugate: A fluorescent dopamine D2 antagonist is prepared as follows: To 10 mg of N-(p- amrnophenethyl)spιperone (Amlaiky et al., FEBS LETT 176, 436 (1984)), and 10 μL N,N- dnsopropylethylamine in 1 mL of DMF is added 15 mg of Compound 31 (Example 32). After 3 hours, the reaction mixture is poured into 5 mL ether. The precipitate is centnfuged, then purified by chromatography on sihca gel using 10-30% methanol in chloroform. Example 38. Protein comugates of sulfonated xanthene dves: A series of dye conjugates of goat anti-mouse IgG or streptavidm are prepared by standard means (Haugland et al., METH. MOL. BIOL. 45, 205 (1995); Haugland, METH. MOL. BIOL. 45, 223 (1995); Haugland, METH. MOL. BIOL. 45, 235 (1995)) using the reactive succimmidyl esters of the following fluorophores: Compound 1, Compound 4, Compound 5, Compound 7, Compound 14 fluorescein, and CY-3, RHODAMINE GREEN, RHODOL GREEN, RHODAMINE RED-X, AND TEXAS RED-X dyes. A solution of the desired protein is prepared at 10 mg/mL in 0.1 M sodium bicarbonate. The labehng reagents are dissolved in DMF or water at 10 mg/mL. Predetermined amounts of the labehng reagents are added to the protein solutions with stirring. A molar ratio of 10 equivalents of dye to 1 equivalent of protein is typical, though the optimal amount varies with the particular labehng reagent, the protein being labeled and the protein's concentration, and is determined empirically. The reaction mixture is incubated at room temperature for one hour or on ice for several hours. The dye— protein conjugate is typically separated from free unreacted reagent bv size- exclusion chromatography on CELLUFINE GH-25 equilibrated with PBS The initial protem- contammg colored band is collected and the degree of substitution is determined from the absorbance at the absorbance maximum of each fluorophore. using the extinction coefficients indicated in Table 4. The absorbance of the dye at 280 nm is subtracted from the total absorbance of the conjugate at 280 nm to get the protein's concentration. Comparison of the absorption of a goat anti-mouse IgG conjugate of Compound 5 (DOS = 7) and a goat anti-mouse IgG conjugate of tetramethylrhodamme (DOS = 4.3) at the same protein concentration is given m Figure 1. The conjugate of the present invention exhibits only one absorption peak (545 nm), whereas the tetramethylrhodamme conjugate exhibits two (558 nm and 522 nm) The 522 nm tetramethylrhodamme peak is due to the presence of nonfluorescent rhodamme dimers. The tendancy of some rhodamme fluorophores to aggregate at moderate to high levels of dye substitution limits the useful signal that can be obtained from those dye-conjugate Table 4: Extinction Coefficients for selected fluorophores of the invention "Extinction coefficients are determined for the free carboxyhc acid in aqueous solution Protein conjugates of antibody fragments, of other avidms and of other proteins are prepared and analyzed similarly Example 39. Fluorescent labehng of periodate-oxidized proteins: Two samples of 5 mg each of goat IgG antibody m 1 mL of 0.1M acetate, 0.135 M NaCl, pH 5.5 are treated with 2.1 mg of sodium metapenodate on ice, for 1 and 2 hours, respectively. The reactions are stopped by addition of 30 μL ethylene glycol. The antibodies are purified on a MATREX GH 25 column (1 cm x 30 cm) packed in PBS pH 7.2. One-tenth volume of 1 M sodium bicarbonate is added to increase the pH and Compound 30 (Example 21) is added at a molar ratio of dye to protein of 100.1. The reaction is stirred for 2 hours at room temperature. Sodium cyanoborohydnde is added to a final concentration of 10 mM and the reaction is stirred for 4 hours at room temperature. The antibody conjugates are purified by dialysis and on MATREX GH 25 columns as described above. Antibodies that are oxidized for 1 hour typically yield a degree of substitution of 1 mole of dye per mole of IgG Antibodies that are oxidized for 2 hours yield a degree of substitution of 1.7 mole of dye per mole of IgG Example 40 Total fluorescence of selected dve-protem comugates as a function of degree of substitution: A series of goat anti-mouse IgG conjugates is prepared as m Example 39 so as to yield derivatives with similar degrees of substitution (DOS) When measured m a fluorometer, fluorescence of the sulfonated-xanthene dye conjugates is typically higher than that of spectrally similar dyes (Table 5). As shown in Figure 2. The fluorescence emission spectra of goat anti-mouse IgG conjugates of Compound 5 (DOS 4.0) and CY-3 (DOS 3 8) at the same solution optical densities reveals substantially enhanced fluorescence by the dye-conjugate of the invention, when excited at 530 nm. Table 5: a. Goat anti-mouse IgG conjugate Furthermore, fluorescence of antibody conjugates of Compounds 1, 4, 5, 7, and 14 do not quench appreciably, even at high relatively degrees of substitution (for instance as shown m Figure 3 for Compound 7 goat anti-mouse IgG conjugate and TEXAS RED-X goat anti-mouse conjugate) Similar results are found with other peptides and proteins, including lectms, protein A, transferrm, fibronectm, enzymes, poproteins, glycoprotems and neuropeptides. Example 41. Labeling R-phvcoervthrm with a thiol-re active sulfonated xanthene dve: Pyridyldisulfide-modified R-phycoerythrm (Molecular Probes, Inc.), 0.9 mg in 160 μL PBS, pH 7.5, is treated with trιs-(2-carboxyethyl)phosphme to reduce the disulfide to a thiol. The thiolated protein is treated with 8 μL of a 20 mg/mL solution of Compound 24 (Example 30) m DMF. Unreacted dye is removed on a spin column. The degree of substitution by the dye is estimated using ε = 52,600 cm^M -1 at 595 nm. The protein concentration is estimated from the absorbance at 488 nm, corrected for the absorbance of Compound 24 at that wavelength Example 42. Fluorescence energy transfer m a sulfonated-rhodamme conmgate of R-phvcoervthrm The R-phycoerythrm conjugate of Example 41 is excited at 488 nm and compared to that of unmodified R-phycoerythrm excited at the same wavelength. Figure 4 shows highly efficient energy transfer from the protein to the sulfonated rhodamme dye. A conjugate of this complex with streptavidm is prepared essentially as described by Haugland (METH. MOL. BIOL. 45, 205 (1995), supra). This conjugate retains the energy transfer properties and is useful for cell staining in flow cytometers that utihze the argon-ion laser for excitation Example 43. Labeling and use of a wheat germ agglutmm dve-comugate- Wheat germ agglutmm (170 mg, EY Laboratories) is dissolved m 5 mL Na2COj. pH 9.0, contaimng 14.9 mg iV-acetylglucosamine. To this is added 14.8 mg of Compound 19 (Example 22). After 1 hour the solution is purified by gel filtration. A degree of substitution of 2-3 dyes per molecule is determined from the absorption at 490 nm. Staphylococcus aureus is stained with the resulting conjugate (Compound 37) for 15 minutes at room temperature. Bacteria stained with Compound 37 are 1.4 times brighter than bacteria similarly stained with a fluorescein wheat germ agglutmm conjugate, when measured by quantitative microscopy. When used according to Sizemore et al. (U.S. Patent No. 5,137,810) Compound 37 can distinguish between Gram positive and Gram negative bacteria. Example 44. Simultaneous labeling of actm and tubuhn in cultured mammalian cells: Bovme pulmonary artery cells (BPAEC) are grown to 30-50% confluence on glass The cells are fixed with 3 7% formaldehyde, permeabihzed with 0 2% Triton X-100, and blocked with 6% bovme serum albumin (BSA) All cells are incubated with mouse monoclonal anti-α-tubuhn for 60 mm. Cells are then washed and divided into two groups for staining. The first group of cells is labeled with a conjugate of goat anti-mouse IgG and Compound 5 for 30 mm, washed, and then incubated with a phalloidm dye-conjugate (Compound 35, Example 33) for an additional 30 mm The second group of cells is labeled with CY-3 conjugated goat anti-mouse IgG for 30 mm and then with fluorescem-conjugated phalloidm Both groups of cells display microtubules decorated with red fluorescence and actin filaments decorated with green fluorescence Quantitative intensity measurements during photobleachmg of the green and red signal on both groups of cells is carried out by exposing the slide to 485 nm excitation, and acqmrmg the green and red cell fluorescence intensity using a CCD camera Fluorescein and CY-3 signals from cells mounted in PBS have lower initial intensities and/or more rapid photobleachmg than Compound 35 and the anti-mouse conjugate of Compound 5, respectively Other cellular components are optionally stained with additional dyes having distinguishable spectra For example, cell nuclei are stained fluorescent blue using DAPI, while other cell antigens are stained deep red fluorescent with antibody conjugates of CY-5 Example 45. Photobleachmg of cells stained with sulfonated xanthene dve-comugates Actm filaments are stained with Compound 35 or fluorescein phalloidm After washing, each sample is continuously illuminated and viewed on a fluorescence microscope Relative photobleachmg rates as shown in Figure 5, clearly demonstrate the superior photostability of the sulfonated rhodamme dye-phalloidm conjugate Example 46 Utility of protein dve-comugates as immunoreagents and resistance to photobleachmg Antibody conjugates of the dyes in Table 5 are prepared with degrees of substitution of approximately 4-6 INOVA shdes are hydrated m 1% bovme serum albumin (BSA) in PBS for 30 minutes. The slide is drained, human auto-antibody is applied, the slide is incubated 30 min and rinsed m PBS. Mouse anti-human antibody is applied, the shde is incubated 30 mm and rmsed in PBS. Each fluorescent anti-mouse antibody conjugate is apphed as a 10 μg/mL solution, diluted m 1% BSA/PBS. After washing and mounting, the samples are viewed through an appropriate filter All samples give predominantly nuclear staining. Quantitative intensity measurements permit comparison of dyes Similar results are obtained using a biotmylated anti-mouse preparation and fluorescent streptavidm conjugates. For photobleachmg measurements, one image of the slide is acquired every 5 seconds for 100 seconds with continuous illumination. Three fields of cells are bleached, and the photobleachmg values are normahzed and averaged (Figure 6). The antibody conjugates of the sulfonated-xanthene dyes are significantly more photostable than other dyes that have comparable spectra, including the CY-3 sulfonated-carbocyanme dye. Example 47. Preparation and use of a fluorescent α-bungarotoxm dve-comugate- α-Bungarotoxm (1 mg) in 25 μL 0.1 M NaHC03 is treated with 1 5 equivalents of Compound 19 (Example 22) at room temperature for 2 hours. The product is purified by size exclusion and ion exchange chromatography. Staining of acetylchohne receptors and detection of their resulting fluorescence is comparable to that of fluorescem-conjugated α-bungarotoxm, except that the fluorescence of the sulfonated-xanthene dye-conjugate is brighter and more resistant to photobleachmg. Example 48 Preparation of ammodextran dve-comugates- 70,000 MW ammodextran (50 mg) deπvatized with an average of 13 ammo groups, is dissolved at 10 mg/mL in 0.1 M NaHCOs. An amme -re active derivative of the sulfonated-xanthene dye is added so as to give dye/dextran ratio of -12. After 6 hours the conjugate is purified on SEPHADEX G-50, elutmg with water. Typically -6 moles of dye are conjugated to 70,000 g dextran. Example 49. Preparation of fluorescent-dve labeled microspheres A variety of methods are used to modify polymeric microspheres with sulfonated xanthene dyes. For example, covalent coupling to amme- or carboxyhc acid-modified microspheres or binding of dye-labeled proteins to microspheres. For example, 1.0 urn amme-deπvatized polystyrene microspheres are suspended at -2% sohds in 100 mM NaHCθ3, pH 8.3 and treated with 2 mg/mL of an amine-reactive sulfonated-xanthene dye. After 1 hour the microspheres are centnfuged and washed with buffer. The larger particles can be analyzed for uniformity of staining and brightness using flow cytometry. Under a microscope the labeled beads appear as spheres with thin rings at their surface. They are particularly useful for cahbration of microscopes, m particular laser-scannmg confocal microscopes, and as photostable standards for flow cytometry. The microspheres can be further coupled to proteins, ohgonucleotides, haptens and other biomolecules for assays using methods well know in the art. Microspheres labeled with the sulfonated-xanthene dyes appear to be more photostable than those that are surface labeled with other dyes having comparable spectra Example 50 Preparation of fluorescent hposomes using the dyes of the invention: The sulfonated-xanthene dyes of the invention are sufficiently water soluble to be incorporated into the interior of hposomes by methods well known m the art (J. BIOL CHEM. 257, 13892 (1982) and PROC. NATL. ACAD. SCI. USA 75, 4194 (1978)). Alternatively, hposomes contaimng sulfonated-xanthenes having a hpophihc substituent (e.g. alkyl having 11-22 carbons), within their membranes are prepared by co-dissolvmg the fluorescent hpid and the unlabeled phosphohpιd(s) that make up the hposome before forming the hposome dispersion essentially as described by Szoka, Jr. et al. (ANN. REV. BIOPHYS. BIOENG. 9, 467 (1980)). Example 51. Preparation of fluorescent dve-comugates of bacteria. Heat-killed Eschenchia coh are suspended at 10 mg/mL in pH 8-9 buffer then incubated with 0 5-1 0 mg/mL of an amme -re active sulfonated xanthene dye After 30-60 minutes the labeled bacteria are centnfuged and washed several times with buffer to remove any unconjugated dye Labeled bacteria that are opsomzed are taken up by macrophage, as determined by flow cytometry Example 52. Preparing DNA hybridization probes using fluorescent nucleotide dve-comugates- For each labehng reaction, a microfuge tube contaimng -1 μg of a -700 bp Hmd III - Bgl II fragment of the E. coh lacZ structural gene is heated for -10 minutes at 95 °C to fully separate the strands. The DNA is cooled on ice. A 2 μL of a 2 mg/mL mixture of random sequence hexanucleotides 0.5 M Tris-HCl, pH 7.2, 0.1 M MgCb, 1 mM dithiothreitol is added, followed by 2 μL of a dNTP labehng mixture (1 mM dATP, 1 mM dGTP, 1 mM dCTP 0 65 mM dTTP and 0 35 mM Compound 36 (Example 35) Sterile water is added to bring the volume to 19 μL. 1 uL Klenow DNA polymerase (2 umts/μL) is added. The samples are incubated 1 hr at 37 °C. The reactions are stopped with 2 μL of 0.2 M EDTA, pH 8.0. The labeled DNA is precipitated with 2.5 uL of 4 M LiCl and 75 μL of -20 °C ethanol. After 2 hours at -20 °C the precipitated nucleic acids are centnfuged at 12.000 rpm. The pellets are washed with cold 70% ethanol, then cold 100% ethanol. The pellets are dried and dissolved in 10 mM Tris-HCl, pH 8.0, 1 mM EDTA. A portion of each sample is analyzed by gel electrophoresis on a 1% agarose mimgel under standard conditions. The labeled DNA products are suitable for in situ hybridization experiments for the detection of RNA or DNA, such as is associated with the E. coli lacZ gene m cells or tissues. Example 53 Incorporation of fluorescent nucleotide comugates into DNA amplification products: A DNA amplification reaction is prepared as follows: 1 uL each of 20 μM solutions of two ohgonucleotide primers that hybridize to the human β-actm gene are added to a labehng reaction containing 5 μL DNA template (100 pmol of a plasmid containing the entire gene), 5 μL 10X reaction buffer (100 mM Tris, pH 8.3, 500 mM KC1), 2.5 μL 1 mM Compound 36 (Example 35), 1 μL 10 mM dATP, 1 μL 10 mM dCTP, 1 μL 10 mM dGTP, 1 5 μL 5 M dTTP, 3 μL 25 mM MgCl 2 , and 28 uL distilled, deiomzed water The sample is transferred to a thermocycler and processed as follows one cycle, 94 °C, 2.5 minutes, 30 cycles, 94 °C, 1 minute, 50 °C, 1 minute, 72 C C, 1 minute, one cycle, 72 °C, 5 minutes; then 4 C C overnight. An ahquot of the sample is mixed with an equal volume of 10% glycerol, loaded onto a 0 9% agarose mmigel and electrophoresed Fluorescent bands of the expected size are visible when the gel is illuminated with 300-nm ultraviolet light Example 54. In situ hybridization of an RNA probe Mouse fibroblasts are fixed and prepared for mRNA in situ hybridization using standard procedures A sulfonated-xanthene RNA probe is prepared by in vitro transcription of a plasmid containing the mouse actm structural gene cloned downstream of a phage T3 RNA polymerase promoter Labehng reactions consist of combining 2 μL DNA template (1 ug DNA), 1 uL each of 10 mM ATP, CTP and GTP, 0 75 μL 10 M UTP, 2 5 μL 1 mM Compound 36 (Example 35), 2 μL 10X transcription buffer (400 mM Tris, pH 8 0, 100 mM MgCb 20 mM spermidine, 100 mM NaCl), 1 μL T3 RNA polymerase (40 units/μL), 1 μL 2 mg/mL BSA, and 8 75 μL water Reactions are incubated at 37 °C for two hours. The DNA template is removed by treatment with 20 units DNase I for 15 minutes, at 37 C C The RNA transcript is purified by extraction with an equal volume of phenol chloroform, 1 1, then by chromatography on SEPHADEX G50 Labeled RNA is denatured for 5 minutes at 50 °C, then hybridized to cellular preparations using standard procedures When preparations are washed and viewed through a fluorescein filter set on a fluorescence microscope, cells expressing actm mRNA show bright green fluorescence Example 55. Discrimination of live and dead cells using the dves of the invention Because of the polarity of the sulfonated-xanthene dyes and their relative impermeability through the membranes of hve cells, the reactive dyes can be used to discriminate cells that have intact versus compromised cell membranes in a single-color assay as follows Mouse monocyte-macrophage, Abelson Leukemia Virus Transformed (RAW264 7) cells are trypsrnized and washed with phosphate buffered saline (PBS), pH 7.2 Approximately 8-10 million cells suspended in 180 μL of PBS, pH 7 2 are placed in a glass test tube and heated in a water bath at 50 °C for 20 minutes to kill a fraction of the cells. Approximately 60 μL (2-3 million cells) of the cell suspension is added to 940 μL of PBS, pH 7.2, followed by 0.1 μL of a 1 mg/mL solution of Compound 1 in DMSO. The mixture is incubated on ice for 30 minutes and washed twice with PBS, followed by addition of 200 μL of PBS, pH 7.2, and 2 μL of a 150 μM solution of propidium iodide in water (as a control for discriminating dead cells). Analysis of the cell suspension using flow cytometry shows that the dead cells (as determined by high red fluorescence) have a mean channel fluorescence (MCF) intensity of about 3100 while the live cells have a MCF intensity of about 50. Alternatively, following the incubation with Compound 1 the cells are fixed with 3% formaldehyde prior to analysis by flow cytometry. Fixation reduces the risk of working with pathogenic cells. Example 56 Preparation and use of an anti-dve comugate to amplify fluorescent labeling- Polyclonal anti-fluorescem, rabbit IgG (Molecular Probes) is conjugated to Compound 19 essentially as described in Example 38 to give Compound 38 A431 cells are stained with 0.125 ug fluorescem-conjugated epidermal growth factor (fluorescein EGF) by standard methods After washing twice with 1% BSA m PBS containing 2 M sodium azide (wash buffer), a portion of the cells are further stained with 3.5 μg of Compound 38. The mixture is incubated on ice for 30 minutes, washed with the wash buffer and analyzed by flow cytometry. Results show an approximate 3-fold amplification in the cell's brightness when amplified using Compound 38 as compared to staimng with fluorescem-EGF alone Additional amplification of the fluorescent signal is achieved by treating the rabbit anti- fluorescem antibodies with an additional anti-rabbit antibody that has been conjugated to additional dyes of the invention (having the same or different spectral properties). Results show an approximate 11-fold amplification of the fluorescent signal when this type of sequential amplification is employed. Example 57 Preparation and use of an anti-dve comugate to quench fluorescence For example, antibodies to the fluorophore of Compound 1 are prepared m rabbits using standard methods and keyhole limpet hemocyanm (KLH) as the immunogen. The resulting antibodies are labeled using Compound 19. The resulting labeled antibody quenches over 90% of the fluorescence of Compound 1 m solution. Example 58. Cell tracing using a hvdrazide-labeled fluorophore: Neurons from zebrafish embryos are microinjected with Compound 33 (Example 33), using standard methods as described by Blankenfeld et al. (J. NEUROSCI. METH. 36, 309 (1991)). The neurons rapidly fill with the dye throughout their volume and their red fluorescence is readily observable, even in their finer processes. The staining is frxable in the cells using formaldehyde and standard fixing methods. Alternatively, the hydrazide dyes or their conjugates are loaded into cells using the sucrose/polyethylene glycol method described by Okada et al. (CELL, 29 33 (1982)) Example 59. Preparation and characterization of a cross-hnked allophycocyamn comugate- A solution of chemically cross-linked allophycocyamn (Yeh et al., CYTOMETRY 8, 91 (1987)) is prepared at a concentration of 10 mg/mL solution m 0.1 M phosphate, 0.1 M NaCl at pH 7.5. A solution of Compound 19 in anhydrous DMF is prepared, at a concentration of 10 mg/mL. An amount of the dye solution is added to the allophycocyamn solution to give a molar ratio of dye to protein of 45, and the solution is stirred. After incubating at room temperature for 1 hour, the reaction is stopped by the addition of 1.5 M hydroxylamme at pH 8.0 m an amount equal to 0.1 of the reaction volume. The reaction mixture is incubated an additional 30 minutes The energy transfer conjugate is purified by size-exclusion chromatography on BioGel P-30 (BioRad). Solutions of cross-hnked APC and the Compound 19 conjugate of cross-hnked APC, at comparable optical densities, are excited at 488 nm and the resulting fluorescence emission spectra are recorded. Cross-hnked allophycocyamn exhibits fluorescence emission at 650 nm when excited at 488 nm. Excitation of the Compound 19 conjugate of the cross-hnked allophycocyamn results in substantially enhanced emission by the allophycocyamn, due to excitation of the sulfonated rhodamme at 488 nm and subsequent efficient energy transfer to the phycobihprotein. as shown m Figure 7. It is to be understood that, while the foregoing invention has been described m detail by way of illustration and example, numerous modifications, substitutions, and alterations are possible without departing from the spirit and scope of the invention as described in the following claims

Claims: What is claimed is: 1. A compound having the formula wherein R 2 , R 3 , R 4 and R 5 are independently H, F, Cl, Br, I, CN; or Ci-Ciβ alkyl. or Ci-Ciβ alkoxy, where each alkyl or alkoxy is optionally further substituted by F, Cl, Br, I, a carboxyhc acid, a salt of carboxyhc acid, or a carboxyhc acid ester of a Ci-Cβ alcohol, or -SO3X where X is H or a counterion R 1 and R 6 are H; or R 1 taken in combination with R 2 , or R 5 taken m combination with R 6 , or both, form a fused aromatic six membered ring that is optionally substituted one or more times by -SO3X; R 7 is H, d-Ciβ alkyl; R 8 and R 9 are independently H, CI-CG alkyl, Ci-Cβ carboxyalkyl, Ci-Ce sulfoalkyl, a salt of Ci- Cβ carboxyalkyl or a salt of Ci-Cβ sulfoalkyl. wherein the alkyl portions are optionally substituted by ammo, hydroxy, carboxyhc acid, a salt of carboxyhc acid, or a carboxyhc acid ester of a CI-CG alkyl; or R 8 in combination with R 9 forms a saturated 5- or 6-membered heterocycle that is a piperidme, a morpholme, a pyrrohdme or a piperazme, each of which is optionally substituted by methyl, carboxyhc acid, a salt of carboxyhc acid, or a carboxyhc acid ester of a Ci-Cβ alkyl; or R 8 in combination with R 2 , or R 9 m combination with R 3 , or both, form a 5- or 6-membered ring that is saturated or unsaturated, and is optionally substituted by one or more Ci-Ce alkyls or -CH2SO3X moieties; where R 17 is H, or Ci-Ciβ alkyl; where R 18 and R 19 are independently H, Ci-Cβ alkyl, CI-CG carboxyalkyl, Ci-Cβ sulfoalkyl, a salt of CI-CG carboxyalkyl, or a salt of Ci-Cβ sulfoalkyl, wherein the alkyl portions are optionally substituted by ammo, hydroxy, carboxyhc acid, a salt of carboxyhc acid, or a carboxyhc acid ester of a Ci-Cβ alkyl; or R 18 m combination with R 19 forms a saturated 5- or 6-membered heterocycle that is a piperidme, a morpholme, a pyrrohdme or a piperazme, each of which is optionally substituted by methyl, carboxyhc acid, a salt of carboxyhc acid, or a carboxyhc acid ester of a CI-CG alkyl; or R 18 m combination with R 4 , or R 19 in combination with R 5 . or both, form a 5- or 6- membered ring that is saturated or unsaturated, and is optionally substituted by one or more Ci-Cβ alkyls or -CH2SO3X moieties; B is O or N + R 18 R 19 , R 10 is H, F, CN, a carboxyhc acid, a salt of carboxyhc acid, or a carboxyhc acid ester of a CI-CG alcohol, or R 10 is a saturated or unsaturated Ci-Ciβ alkyl that is optionally substituted one or more times by F, Cl, Br, carboxyhc acid, a salt of carboxyhc acid, a carboxyhc acid ester of a CI-CG alcohol, -SO3X, ammo, alkylammo, or dialkylammo, the alkyl groups of which have 1-6 carbons, or R 10 has the formula where R 12 , R 13 , R 14 , R 15 and R 16 are independently H, F, Cl, Br, I, -SO3X, a carboxyhc acid, a salt of carboxyhc acid, CN, mtro, hydroxy, azido, ammo, hydrazino; or Ci-Ciβ alkyl, Ci-Ciβ alkoxy, Ci-Ciβ alkylthio, Ci-Cis alkanoylamino, Ci-Ciβ alkylaminocarbonyl, C2-C36 dialkylaminocarbonyl, Ci-Ciβ alkyloxycarbonyl, or Cβ-Cis arylcarboxamido, the alkyl or aryl portions of which are optionally substituted one or more times by F, Cl, Br, I, hydroxy, carboxyhc acid, a salt of carboxyhc acid, a carboxyhc acid ester of a Ci-Cβ alcohol, -SO3X, ammo, alkylammo, dialkylammo or alkoxy, the alkyl portions of each having 1-6 carbons; or one pair of adjacent substituents R 13 and R 14 , R 14 and R 15 or R 15 and R 16 , when taken in combination, form a fused 6-membered aromatic ring that is optionally further substituted by carboxyhc acid, or a salt of carboxyhc acid; and R 11 is H, hydroxy, CN or a Ci-Cβ alkoxy; or R 10 in combination with R 11 forms a 5-membered spirolactone ring or a 5-membered spirosultone ring; or R 11 in combination with R 12 forms a 5- or 6- membered spirolactone ring or a 5- or 6-membered spirosultone ring that is optionally and independently substituted by H, F or CH3; or R 10 when taken in combination with R 11 is a carbonyl oxygen; provided that where A is OR 7 , R 12 , if present, is -SO3X; and provided that at least one of R 2 , R 3 , R 4 , and R 5 is -SO3X, or R 8 in combination with R 2 , or R 9 in combination with R 3 , or R 18 in combination with R 4 , or R 19 in combination with R 5 , form a 5- or 6- membered ring that is saturated or unsaturated, and is substituted by at least one -CH2SO3X moiety 2. A compound, as claimed m Claim 1, wherein one or more of R 2 , R 3 , R 4 , R 3 , R 7 , R 8 , R 9 , R 10 , R 12 , R 13 , R 14 , R 15 , R 16 , R 17 , R 18 , or R 19 is or is modified to be -L-R x or -L-S c ; wherein each L is optionally the same or different and is a covalent hnkage; each Rx is optionally the same or different and is a reactive group; and each Sc is optionally the same or different and is a conjugated substance 3 A compound, as claimed in Claim 2, wherein one of R 13 , R 14 , R 13 , and R 16 is -L-R x or -L-S c 4. A compound, as claimed m Claim 2, wherein one of R 7 , R 8 , R 9 , R 17 , R 18 , and R 19 is -L-R x or -L-S c 5. A compound, as claimed in Claim 2, wherein each L is independently a single covalent bond, or L is a covalent hnkage having 1-24 nonhydrogen atoms selected from the group consisting of C, N, 0, P, and S and is composed of any combination of single, double, tnple or aromatic carbon-carbon bonds, carbon-mtrogen bonds, nitrogen-nitrogen bonds, carbon-oxygen bonds, carbon— sulfur bonds, phosphorus-oxygen bonds, and phosphorus- nitrogen bonds; each Rx is an acrylamide, an activated ester of a carboxyhc acid, a hydroxy, an aldehyde, an alkyl hahde, a sulfonate, an amme, an anhydride, an anihne, an aryl hahde, an azide, an azrridine, a boronate, a carboxyhc acid, a carbodumide, a diazoalkane, an epoxide, a glycol, a haloacetamide, a halotnazine, a hydrazme, a hydroxylamme, an lmido ester, an isocyanate, an isothiocyanate, a ketone, a maleimide, a phosphoramidite, a sulfonyl hahde, or a thiol group; and each S c is an a mo acid, peptide, protein, monosacchande, disacchande, polysacchande, lon-complexmg moiety, nucleotide, nucleic acid polymer, hapten, drug, hpid, hpid assembly, non- biological orga c polymer, polymeric micr op article, animal cell, plant cell, bacterium, yeast, virus, or protist. 6. A compound, as claimed in Claim 2, wherein L is a single covalent bond and R x is a carboxyhc acid, an activated ester of a carboxyhc acid, an amme, an azide, a hydrazme, a haloacetamide, an alkyl hahde, an isothiocyanate, or a maleimide group. 7 A compound, as claimed m Claim 2 wherein S c is a peptide, protein, polysacchande, nucleotide, or nucleic acid polymer. 8. A compound, as claimed m Claim 7, wherein S c is an antibody, an avidin, a streptavidm, a lectin, a growth factor, an actm, or a toxm. 9. A compound, as claimed in Claim 7, wherein S c is a phycobihprotein that is optionally chemically cross-linked. 10. A compound, as claimed in Claim 9, wherein the phycobihprotein is an allophycocyamn 11. A compound, as claimed in Claim 9, wherein the phycobihprotein further comprises a chemically reactive group or a conjugated substance 12 A compound, as claimed m Claim 7, 8, 9, 10, or 11 wherein S c is further substituted by one or more additional fluorescent or non-fluorescent dyes 13. A compound, as claimed in any of Claims 1-9, wherein R 3 and R 4 are each -SO3X 14. A compound, as claimed in Claim 13, wherein A is OR 7 , B is O, C is OR 17 , and R 2 and R 5 are independently F or Cl. 15. A compound, as claimed in any of Claims 1-9, wherein R 10 has the formula wherein R 12 is a carboxyhc acid, a salt of carboxyhc acid, or -SO3X; R 11 is not present; and either (1) at least three of R 13 , R 14 , R 15 , and R 16 are F or Cl; or (n) one of R 14 and R 15 is a carboxyhc acid or salt of a carboxyhc acid or is -S-(CH2)nCOOH, wherein n is 1-15, and the other of R 14 or R 13 is H, F or Cl. 16 A compound, as claimed m any of Claims 1-9, wherein A is NR 8 R 9 , B is O and C is OR 17 17. A compound, as claimed m any of Claims 1-9, wherein A is NR 8 R 9 , B is N + R 18 R 19 , and C is NR i sR 19 ; and either (1) R 8 in combination with R 2 forms a 5- or 6-membered ring that is saturated or unsaturated, and is optionally substituted by one or more CI-CG alkyls or -CH2SO3X moieties; and R 19 in combination with R 5 forms a 5- or 6-membered ring that is saturated or unsaturated, and is optionally substituted by one or more Ci-Cβ alkyls or -CH2SO3X moieties; or (II) R 9 and R 18 are independently H, CI-CG carboxyalkyl, a salt of Ci-Cβ carboxyalkyl, CI-CG sulfoalkyl, or a salt of CI-CG sulfoalkyl; or (III) R 8 in combination with R 2 , and R 19 in combination with R 3 , each form a 5- or 6- membered ring that is saturated; and R 3 and R 4 are each -SO3X; or (IV) R 8 in combination with R 2 forms a 5- or 6-membered ring that is saturated or unsaturated, and is substituted by -CH2SO3X; and R 19 in combination with R 5 forms a 5- or 6-membered ring that is saturated or unsaturated, and is substituted by -CH2SO3X. 18. A compound, as claimed m any of Claims 1-9, wherein R 1 , R 2 , R 3 , and R 6 are H; R 3 and R 4 are each -SO3X; and R 8 , R 9 , R 18 , and R 19 are H, Ci-Cβ alkyl, CI-CG carboxyalkyl, Cι-C 6 sulfoalkyl, a salt of Cι-C 6 carboxyalkyl, or a salt of Ci-Cβ sulfoalkyl. 19. A compound, as claimed in any of Claims 1-9, having the formula wherein R 2 , R 3 , R 4 and R 5 are independently H, F, Cl, Br, I, Ci-Ciβ alkyl, Ci-Ciβ alkoxy, or -SO3X, R 8 and R 9 are independently H, Ci-Cβ alkyl, Ci-Cβ carboxyalkyl, a salt of Ci-Cβ carboxyalkyl, Ci-Ce sulfoalkyl, or a salt of Ci-Cβ sulfoalkyl; or R 8 in combination with R 2 forms a 5- or 6-membered ring that is saturated or unsaturated, and that is optionally substituted by one or more Ci-Cc, alkyls or -CH2SO3X moieties; R 18 and R 19 are independently H, Ci-Cβ alkyl, Ci-Cβ carboxyalkyl, a salt of Ci-Cβ carboxyalkyl, Ci-Cβ sulfoalkyl, or a salt of Ci-Cβ sulfoalkyl, or R 19 in combination with R 5 forms a 5- or 6-membered ring that is saturated or unsaturated, and that is optionally substituted by one or more CI-CG alkyls or -CH2SO3X moieties; R 12 , R 13 , R 14 , R 15 and R 16 are independently H, Cl, F, ammo, mtro, -SO3X, a carboxyhc acid, a salt of carboxyhc acid, or -S-(CH2)nCOOH where n = 1-15; provided that either (ι)R 3 and R 4 are each -SOsX; or (n) R 8 m combination with R 2 forms a 5- or 6-membered ring that is saturated or unsaturated, and is substituted -CH2SO3X; and R 19 in combination with R 5 forms a 5- or 6- membered ring that is saturated or unsaturated, and is substituted by -CH2SO3X. 20. A method of staining a biological sample, comprising the steps of: a) combimng a dye solution comprising a compound as claimed in any of claims 1-18 with a biological sample in a concentration sufficient to yield a detectable optical response under the desired conditions; b) illuminating said sample at a wavelength selected to elicit said optical response. 21 A method, as claimed m Claim 20, further comprising (1) combining the sample with an additional detection reagent that has spectral properties that are detectably different from said optical response; and/or (n) determining a characteristic of the sample by comparing the optical response with a standard response parameter; and/or (m) tracing the temporal or spatial location of the optical response withm the sample. 22 A method, as claimed m Claim 21(ιι), wherein the sample comprises cells, and the characteristic determined is the viability of the cells. 23. A method, as claimed m Claim 20, wherein the sample comprises cells, and the step of combining comprises electroporation, shock treatment, high extracellular ATP, pressure micro jection, scrape loading, patch clamp loading, phagocytosis, or osmotic lysis of pinocytic vesicles. 24. A kit, compnsing one or more compounds as claimed in any of claims 1-19. 25. A complex, comprising a dye-conjugate as claimed in any of claims 2-18 wherein Sc is a member of a specific binding pair that is associated non-covalently with the complementary member of the specific binding pair. 26. A complex, as claimed in Claim 25, wherein the specific binding pan: is selected from the following parrs: antigen — antibody biotm — avidin biotin — streptavidin biotin — anti-biotin immunoglobuUn G — protein A immunoglobuUn G — protein G drug — drug receptor toxm — toxin receptor carbohydrate — lectin carbohydrate — carbohydrate receptor peptide — peptide receptor protein — protein receptor enzyme substrate — enzyme DNA— aDNA RNA— aRNA hormone — hormone receptor ion — chelator.

Inventors: HAUGLAND RICHARD P, LEUNG WAI-YEE, MAO FEI, HAUGLAND, RICHARD, P., LEUNG, WAI-YEE, MAO, FEI
Applicants: HAUGLAND RICHARD P, LEUNG WAI YEE, MAO FEI, MOLECULAR PROBES INC, HAUGLAND, RICHARD, P., LEUNG, WAI-YEE, MAO, FEI, MOLECULAR PROBES, INC.
Application year: 1998
Main classification: C07D311
IPC codes: C07D311, C07D405, C07D491, C07H21, C09B11, G01N1, G01N33